Gaudium IVF Changes Corporate Identification Number to L85100DL2015PLC278296, Status Updated to Listed
Gaudium IVF and Women Health Limited's Corporate Identification Number (CIN) changed from U85100DL2015PLC278296 to L85100DL2015PLC278296. The company's status has been updated from 'Unlisted' to 'Listed' following its listing on NSE and BSE. Authorized capital is ₹44 crore, paid-up capital is ₹36.39 crore.
The change in CIN and status is a regulatory and administrative update. It does not directly impact the company's business operations, financial performance, or market position in a significant way.
The announcement pertains to a change in the company's CIN and its status from unlisted to listed, which is a procedural update. It does not inherently carry positive or negative financial or operational implications.
Gaudium IVF and Women Health Limited has announced a change in its Corporate Identification Number (CIN). The CIN has been updated from <U85100DL2015PLC278296° to ‘L85100DL2015PLC278296’. This change coincides with the update of the Company's status from ‘Unlisted’ to ‘Listed’, following the listing of its equity shares on the National Stock Exchange of India Limited and BSE Limited.
The company's master data, as available on the Ministry of Corporate Affairs (MCA) V3 Portal, reflects these changes. The updated CIN is L85100DL2015PLC278296, and the company name remains Gaudium IVF and Women Health Limited. The ROC Name is ROC Delhi, and the Registration Number is 278296. The Date of Incorporation is March 24, 2015. The company is listed on stock exchanges (Y/N: Yes), and its status is active and compliant.
The authorized capital is ₹44,00,00,000, and the paid-up capital is ₹36,39,34,420. The date of the last AGM is scheduled for September 27, 2025, and the balance sheet date is March 31, 2025. The registered office is located at B1/51, Janakpuri, New Delhi-110058.
What to do with a filing like this
Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.